29 The procedure is costly, painful, and has an increasing risk of infection and sepsis.30-32 While clinical assessment tools, such as the PCPTRC, have value in assessing risk, improvements in patient selection for biopsy can dramatically reduce cost and complications.33 In this study, both ...
TB HIV co-infectionDetermine® lateral flow lipoarabinomannan assay (LF-LAM)Early morning urine (EMU)Urine LAM testing has been approved by the WHO for use in hospitalised patients with advanced immunosuppression. However, sensitivity remains suboptimal. We therefore examined the incremental diagnostic...